GL1X · GenesisL1 explorer

Research workbench

The structure of the humanised A33 Fab C226S variant, an immunotherapy candidate for colorectal cancer

Analyse The structure of the humanised A33 Fab C226S variant, an immunotherapy… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7NC0
Type
protein
Length
426 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
A33 Fab light chain; A33 Fab heavy chain
Pockets
3 · best druggability 0.51

Structure

x-ray diffraction · 2 distinct chains · 7% helix, 50% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
LA33 Fab light chainprotein2135% helix, 51% strand—
HA33 Fab heavy chainprotein2139% helix, 48% strand—

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13260.510.7349empty
21360.390.7328empty
31070.360.7425empty

Interfaces

1 interface between chains.

  • L–H · 1692 Ų buried · 15 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 7NC0 · The structure of the humanised A33 Fab C226S variant, an immunotherapy candidate for… · the same entry in another collection · chain L against L, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.